Decoy Therapeutics Inc (DCOY)
Decoy Therapeutics Inc. is a Cambridge, Massachusetts-based biotechnology company listed on NASDAQ under the ticker DCOY. The company is focused on advancing peptide conjugate therapeutics through its IMP3ACT platform, which is designed to streamline drug development and manufacturing. According to the company, this technology combines machine learning and artificial intelligence with synthesis methods to help engineer, optimize, and produce peptide conjugates. Decoy Therapeutics is building a portfolio of candidates aimed at unmet needs in infectious diseases and oncology. The company was previously known as Salarius Pharmaceuticals, Inc. and adopted its current name in January 2026.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-DCOY
|
$8.77
|
70.1% Upside
|
Bargain
|
$30
|
482.3% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 5, 2026
|
-0.2x
|
0.7x
|
—
|
2.822 M
|
-5.113 M
|
0.0%
|
99.4%
|
-34.0
|
—
|
50.1%
|
